IGeneTech Bioscience Co., Ltd.

Home
China
Beijing
IGeneTech Bioscience Co., Ltd.

A high-tech enterprise certified by ISO 13485 and ISO 9001 QMS.

iGeneTech is founded in 2014, and has 3 technology platforms: NGS probe hybridization, multiplex PCR primer design and high-throughput oligo pools synthesis with intellectual property rights.

27/05/2026

Discover the next-gen TAPS+ Library Capture Solution by iGenetech! With TAPS+, preserve genome integrity and enrich methylation research. Elevate your sequencing with high efficiency and low variance. Explore the innovation in methylation detection now!

https://www.igenetech.com/blog/igenetech-launches-taps-library-capture-solution

TAPS+ Positive Methylation Library Construction SolutionIn the native mammalian genome, unmethylated cytosines account for over 95%, while methylated cytosines (C) make up less than 5%. Conventional B...

09/05/2026

🎉 iGeneTech relies on its proprietary liquid-phase chip capture technology, using denser probes for high-GC regions, optimized probe layout, and improved hybrid capture reagent systems to enhance capture efficiency in complex regions.

🔍 GeneMind has broken through difficult sequencing regions with its CMS sequencing technology, further improving performance in high-GC regions and reducing coverage gaps.

https://www.linkedin.com/pulse/when-whole-exome-sequencing-meets-high-gc-regions-how-overcome-oqw6c?trackingId=jncoqkcAyTgqx8u%2FSCCgtg%3D%3D&lipi=urn%3Ali%3Apage%3Ad_flagship3_company_posts%3BR%2Fizy4v4Q6mexn1XJiRS%2Fw%3D%3D

Application Background In the field of genetic disease testing, Whole Exome Sequencing (WES) has become an important first-line method. Compared with single-gene testing or disease panels, WES covers more than 20,000 gene coding regions in a single test, providing comprehensive genetic information f

07/05/2026

🎉 iGeneTech has launched a detection solution for hantavirus and a multi-pathogen mixed whole-genome capture probe panel, supporting both manual and automated workflows and compatible with multiple sample types. This solution provides technical support for infectious disease prevention and control in closed spaces, enabling efficient and accurate detection, genotyping, and source tracing.

https://www.linkedin.com/pulse/cruise-ship-hantavirus-alert-igenetech-launches-sewage-monitoring-jiylc?trackingId=1LtI2tManpJMHGvUmtH1iw%3D%3D&lipi=urn%3Ali%3Apage%3Ad_flagship3_company_posts%3BbIs0AoRMRP2gQRABsbnBJg%3D%3D

Foreword iGeneTech has launched a detection solution for hantavirus and a multi-pathogen mixed whole-genome capture probe panel, supporting both manual and automated workflows and compatible with multiple sample types. This solution provides technical support for infectious disease prevention and co

30/04/2026

🔍 iGeneTech launches a norovirus whole-genome capture probe detection solution, supporting both manual and automated workflows, compatible with multiple sample types, and enabling efficient and accurate detection, genotyping, and source tracing.

https://www.linkedin.com/pulse/igenetech-norovirus-probes-broad-spectrum-high-sensitivity-automated-tn32c/?trackingId=sCyhF%2BbfHxewR6C%2FToFs4Q%3D%3D

Foreword iGeneTech launches a norovirus whole-genome capture probe detection solution, supporting both manual and automated workflows, compatible with multiple sample types, and enabling efficient and accurate detection, genotyping, and source tracing. Background Norovirus infection is a common inte

29/04/2026

Using TCR and BCR sequencing on peripheral blood mononuclear cells (PBMC) from patients after kidney transplantation, the study revealed characteristic immune repertoire patterns in T cell–mediated rejection (TCMR), antibody–mediated rejection (ABMR), and mixed rejection. This is the first systematic exploration of the value of immune repertoire sequencing for precise classification of renal transplant rejection.

iGeneTech is proud to have provided the immune repertoire profiling solution for this study, offering new insights into rejection monitoring and anti–rejection therapy for kidney transplant recipients.

Research Highlights A team from Zhongshan Hospital, Fudan University, published a study entitled Immune repertoire sequencing for precision diagnosis in kidney transplantation in Journal of Translational Medicine. Using TCR and BCR sequencing on peripheral blood mononuclear cells (PBMC) from patient

14/04/2026

🔍 Based on its independently developed IGT® Oligo Pools synthesis platform and TargetSeq® technology platform, the company has built a product matrix covering nearly 30 core species. 🧬 Among them, the Barley Whole Exome Solution features high uniformity and high specificity, providing reliable tools for genomic research and molecular breeding. 🧐

https://www.linkedin.com/pulse/igenetech-barley-whole-exome-panel-empowers-precision-genomic-xfz3c/?trackingId=kwrp9%2BCM%2FcJYZOBUaKXAEg%3D%3D

As Qingming Festival approaches, barley in fields enters the critical heading and booting stage. As an important raw material for grain, forage and beer brewing in China, high yield and stress resistance of barley are expected in spring farming, and also key topics in agricultural genomics research.

10/04/2026

🧬 iGeneTech launches the upgraded IGT® Long-Read DNA Library Prep Kit V2.

Equipped with proprietary long-fragment library purification magnetic beads, this kit enables high-quality long-fragment library construction and supports downstream hybridization capture workflows, providing a more efficient and flexible solution for long-read target region research. It better supports third-generation sequencing and fully unlocks the advantages of long-read technology.

https://www.linkedin.com/pulse/igt-long-read-dna-library-prep-kit-v2-new-launch-igenetech-dmxfc/?trackingId=zIXQO0oQcJpm1P6SeY6NSg%3D%3D

With the rapid development of third-generation sequencing, long-read applications have placed higher demands on library preparation. Whether for complex region analysis, structural variation detection, or long-fragment targeted sequencing, the fragment length, integrity, yield and stability of the l

02/04/2026

💡 iGeneTech launches four syndrome pathogen identification panels covering 184 common pathogens. Paired with the IGT-AS01 automated workstation, the solution supports both manual and automated workflows, is compatible with diverse sample types, and requires no pre-cultivation or host depletion. It enables accurate pathogen identification and delivers an end-to-end solution for public health prevention, control, and research surveillance.

https://www.linkedin.com/pulse/fully-automatic-more-precise-igenetech-launches-integrated-solution-em7hc/?trackingId=WVsXlfItxAQ0TsW8iRirZg%3D%3D

Foreword iGeneTech launches four syndrome pathogen identification panels covering 184 common pathogens. Paired with the IGT-AS01 automated workstation, the solution supports both manual and automated workflows, is compatible with diverse sample types, and requires no pre-cultivation or host depletio

30/03/2026

Based on its independently developed core technology of TargetSeq® liquid-phase probe capture, iGeneTech has launched a Measles Morbillivirus Panel to support prevention and control.

https://www.linkedin.com/pulse/igenetech-whole-genome-capture-solution-measles-igenetech-bxhoe/?trackingId=QMSkXADYX%2BchiViQAxIzNw%3D%3D

Recently, measles outbreaks have rebounded in many parts of the world, with the situation in the United States being particularly severe. Surveillance data show that 1,136 measles cases have been reported in the United States since 2026, and the number of cases reported in the first 8 weeks alone is

24/03/2026

🧑‍⚕️ As an upstream kit developer for gene detection, iGeneTech has been deeply engaged in the field for 12 years, focusing on clinical needs, providing professional targeted capture solutions for clinical and scientific research institutions, and offering personalized customization services.

💡 We can customize exclusive detection solutions on demand, helping the standardized and large-scale implementation of DNA+RNA co-detection technology, enabling accurate detection to match targeted drugs, and jointly building a defense line for tumor precision diagnosis and treatment. 🧬

https://www.linkedin.com/pulse/importance-preventing-missed-detection-fusion-genes-igenetech-kkwac/?trackingId=QCniTRhvST63cgY5sVbw2g%3D%3D

Fusion genes are the "golden targets" for precision tumor therapy. Different from ordinary gene mutations, a fusion gene is a chimeric gene formed by the recombination of partial or complete sequences of two different genes.

Address

Level 3, Block A, Building 9, No. 8 Shengmingyuan Road, Changping District
Beijing
102200

Website

https://www.igenetech.com/

Alerts

Be the first to know and let us send you an email when IGeneTech Bioscience Co., Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your business to be the top-listed Business in Beijing?